Search

Your search keyword '"Crane JK"' showing total 73 results

Search Constraints

Start Over You searched for: Author "Crane JK" Remove constraint Author: "Crane JK"
73 results on '"Crane JK"'

Search Results

1. The effect of different antibiotic combinations in calcium sulfate cement on the growth of Cutibacterium acnes and Staphylococcus periprosthetic shoulder infection isolates.

2. SOS-Inducing Drugs Trigger Nucleic Acid Release and Biofilm Formation in Gram-Negative Bacteria.

3. Role of Extracellular DNA in Bacterial Response to SOS-Inducing Drugs.

4. Inhibition of SOS Response by Nitric Oxide Donors in Escherichia coli Blocks Toxin Production and Hypermutation.

5. Cross-Talk between Probiotic Nissle 1917 and Human Colonic Epithelium Affects the Metabolite Composition and Demonstrates Host Antibacterial Effect.

6. Psychoactive Drugs Induce the SOS Response and Shiga Toxin Production in Escherichia coli .

7. Role of the SOS Response in the Generation of Antibiotic Resistance In Vivo .

8. Spatio-temporal focal spot characterization and modeling of the NIF ARC kilojoule picosecond laser.

9. Pathogenic genetic variations of C. acnes are associated with clinically relevant orthopedic shoulder infections.

10. Metal Nanoparticles in Infection and Immunity.

11. Effect of Blue Light and Photosensitizers on Cutibacterium acnes on Shoulder Periprosthetic Joint Infection Isolates.

12. Injection laser system for Advanced Radiographic Capability using chirped pulse amplification on the National Ignition Facility.

13. Hemolysis Is a Diagnostic Adjuvant for Propionibacterium acnes Orthopaedic Shoulder Infections.

14. Zinc Blockade of SOS Response Inhibits Horizontal Transfer of Antibiotic Resistance Genes in Enteric Bacteria.

15. Intrathecal spinal abscesses due to Candida albicans in an immunocompetent man.

16. Immunomodulatory Effects of Antimicrobial Drugs.

17. Zinc blocks SOS-induced antibiotic resistance via inhibition of RecA in Escherichia coli.

18. Propionibacterium acnes Susceptibility and Correlation with Hemolytic Phenotype.

19. Biological Activities of Uric Acid in Infection Due to Enteropathogenic and Shiga-Toxigenic Escherichia coli.

20. Authors' response.

21. Immunotherapy for Infectious Diseases: Past, Present, and Future.

22. Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.

23. Zinc protects against Shiga-toxigenic Escherichia coli by acting on host tissues as well as on bacteria.

24. Hemolysis as a clinical marker for propionibacterium acnes orthopedic infection.

25. Pro-inflammatory effects of uric acid in the gastrointestinal tract.

28. Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli.

29. Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery.

30. Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli.

31. FRAX® counseling for bone health behavior change in women 50 years of age and older.

33. Virulence inhibition by zinc in shiga-toxigenic Escherichia coli.

34. Phasing beams with different dispersions and application to the petawatt-class beamline at the National Ignition Facility.

35. Feedback effects of host-derived adenosine on enteropathogenic Escherichia coli.

37. Effect of zinc in enteropathogenic Escherichia coli infection.

38. Ecto-5'-nucleotidase and intestinal ion secretion by enteropathogenic Escherichia coli.

39. Mutual enhancement of virulence by enterotoxigenic and enteropathogenic Escherichia coli.

40. Two pathways for ATP release from host cells in enteropathogenic Escherichia coli infection.

41. Externalization of host cell protein kinase C during enteropathogenic Escherichia coli infection.

42. Pulmonary mucormycosis in a patient with chronic obstructive pulmonary disease: diagnosis by fine needle aspiration cytology.

43. Release of ATP during host cell killing by enteropathogenic E. coli and its role as a secretory mediator.

44. Role of EspF in host cell death induced by enteropathogenic Escherichia coli.

45. Characterization of fusion burn time in exploding deuterium cluster plasmas

46. Redistribution of cyclic GMP in response to sodium butyrate in colon cells.

47. Preformed bacterial toxins.

48. Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.

49. Host cell death due to enteropathogenic Escherichia coli has features of apoptosis.

50. Toxic shock syndrome after mastoidectomy.

Catalog

Books, media, physical & digital resources